Sanjari Pirayvatlou Peyman, Roushan Nader, Sanjari Pirayvatlou Pouyan, Majidi Alireza, Khorshidi Zeinab
Department of General Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Department of Internal Medicine, Division of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
J Family Med Prim Care. 2022 Dec;11(12):7720-7724. doi: 10.4103/jfmpc.jfmpc_922_22. Epub 2023 Jan 17.
Hilar cholangiocarcinoma (HCCA) is a rare malignancy in patients with biliary disease. If jaundice and obstruction before surgery are left untreated, then they can cause side effects such as cholangitis, delayed tumor treatment, decreased quality of life, and increased mortality. Surgery is the main treatment for HCCA. Therefore, this study was performed to compare the efficacy and complications of percutaneous transhepatic biliary drainage (PTBD) and endoscopic biliary drainage (EBD).
This cohort study was conducted on 20 patients with biliary obstruction who had been selected by simple random sampling and divided into two groups of EBD and PTBD. Three weeks after surgery, patients were compared in terms of bilirubin levels and postoperative complications. Data were analyzed by descriptive statistics (table, mean, and standard deviation) and inferential statistics (independent t-test, Chi-square test, and Fisher's test).
Independent -test did not show a significant difference between the two groups in terms of bilirubin level ( = 0.77). However, despite a decrease in bilirubin level in both groups, independent t-test showed that this difference was not significant ( = 0.08). Fisher's exact test showed a significant difference between the two groups in terms of postoperative complications ( = 0.02).
Using both drainage methods before surgery reduced bilirubin levels in patients, but EBD method had fewer side effects than PTBD method. The EBD method was performed under the direct supervision of a gastroenterologist. In performing this procedure, specialist physicians should have more supervision.
肝门部胆管癌(HCCA)是胆道疾病患者中一种罕见的恶性肿瘤。如果术前的黄疸和梗阻未得到治疗,那么它们会引起诸如胆管炎、肿瘤治疗延迟、生活质量下降以及死亡率增加等副作用。手术是HCCA的主要治疗方法。因此,本研究旨在比较经皮经肝胆道引流(PTBD)和内镜下胆道引流(EBD)的疗效及并发症。
本队列研究对20例胆道梗阻患者进行,这些患者通过简单随机抽样选取,并分为EBD组和PTBD组。术后三周,比较患者的胆红素水平和术后并发症。数据通过描述性统计(表格、均值和标准差)和推断性统计(独立t检验、卡方检验和费舍尔检验)进行分析。
独立t检验显示两组在胆红素水平方面无显著差异(P = 0.77)。然而,尽管两组胆红素水平均有所下降,但独立t检验表明这种差异不显著(P = 0.08)。费舍尔精确检验显示两组在术后并发症方面存在显著差异(P = 0.02)。
术前使用两种引流方法均可降低患者的胆红素水平,但EBD方法的副作用比PTBD方法少。EBD方法是在胃肠病学家的直接监督下进行的。在实施该操作时,专科医生应进行更多监督。